Last update 25 Apr 2026

NNC0361-0041

Overview

Basic Info

Drug Type
DNA vaccine, Therapeutic vaccine
Synonyms
DNA vaccine targeting PPI/TGF-β1/IL-10/IL-2 (Novo Nordisk), NN-9041, NNC0361-0041
Target
insulin
Action
modulators
Mechanism
insulin modulators(insulin modulators)
Therapeutic Areas
Immune System DiseasesEndocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Diabetes Mellitus, Type 1
Originator Organization
Novo Nordisk A/SNovo Nordisk A/S
Active Organization-
Inactive Organization
Novo Nordisk A/SNovo Nordisk A/S
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with NNC0361-0041
NCT04279613
/ CompletedPhase 1IIT
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Administered Subcutaneously to Patients With Type 1 Diabetes Mellitus
100 Clinical Results associated with NNC0361-0041
Login to view more data
100 Translational Medicine associated with NNC0361-0041
Login to view more data
100 Patents (Medical) associated with NNC0361-0041
Login to view more data
100 Deals associated with NNC0361-0041
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 1Phase 1
United States
Novo Nordisk A/SNovo Nordisk A/S
23 Nov 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT04279613 (TOPPLE T1D, CTgov)
Phase 1
Diabetes Mellitus, Type 1
47
Placebo
rrhgqcgbkw = hgvaczobpa ttwlulprmy (yqblwwaycf, bzwekgrqbw - skpaskmjoe)
View more
-
20 May 2025
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free